» Articles » PMID: 39870872

Engineering Mycobacteria for Vaccination and Controlled Human Infection Studies

Overview
Journal Nat Microbiol
Date 2025 Jan 27
PMID 39870872
Authors
Affiliations
Soon will be listed here.
References
1.
Mangtani P, Abubakar I, Ariti C, Beynon R, Pimpin L, Fine P . Protection by BCG vaccine against tuberculosis: a systematic review of randomized controlled trials. Clin Infect Dis. 2013; 58(4):470-80. DOI: 10.1093/cid/cit790. View

2.
Darrah P, Zeppa J, Maiello P, Hackney J, Wadsworth 2nd M, Hughes T . Prevention of tuberculosis in macaques after intravenous BCG immunization. Nature. 2020; 577(7788):95-102. PMC: 7015856. DOI: 10.1038/s41586-019-1817-8. View

3.
Morrison H, Jackson S, McShane H . Controlled human infection models in COVID-19 and tuberculosis: current progress and future challenges. Front Immunol. 2023; 14:1211388. PMC: 10248465. DOI: 10.3389/fimmu.2023.1211388. View

4.
Kleinwaks G, Schmit V, Morrison J . Considering human challenge trials for tuberculosis vaccine development. Vaccine. 2021; 40(2):173-174. DOI: 10.1016/j.vaccine.2021.11.024. View

5.
Blazevic A, Xia M, Turan A, Tennant J, Hoft D . Pilot studies of a human BCG challenge model. Tuberculosis (Edinb). 2017; 105:108-112. DOI: 10.1016/j.tube.2017.05.001. View